Showing results (2151-2160 of 2,301) with videos related to

Sort By:
Pageof 231
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2018
Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell TransplantationLinda J Burns, Beatrice Abbetti, Stacie D Arnold, et al.
The Lancet. Diabetes & Endocrinology|November 9, 2025
Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based studyJoanna Y Gong, Jedidiah I Morton, Lei Chen, et al.
The Lancet. Diabetes & Endocrinology|March 12, 2026
Trends in cause-specific mortality among people with and without diabetes in high-income settings: a multinational, population-based studyDianna J Magliano, Jedidiah I Morton, Lei Chen, et al.
JAMA Network Open|May 5, 2026
Hematopoietic Cell Transplant Access and Patient DiversityRachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Neuron|October 23, 2018
ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUSJone López-Erauskin, Takahiro Tadokoro, Michael W Baughn, et al.
Transplantation and Cellular Therapy|April 21, 2022
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesRachel Phelan, Min Chen, Caitrin Bupp, et al.
British Journal of Anaesthesia|March 24, 2024
International consensus is needed on a core outcome set to advance the evidence of best practice in cancer prehabilitation services and researchAnna M Myers, Rachael C Barlow, Gabriele Baldini, et al.
Elife|February 13, 2019
Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axisShuo-Chien Ling, Somasish Ghosh Dastidar, Seiya Tokunaga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Transplantation and Cellular Therapy|December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical TrialBronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.
Pageof 231